selenium atom/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
selenium atom — no detected effect on health-related quality of life
Evidence strength: moderate.FindingNull resultreplicated ×1“No statistically significant difference in the EORTC QLQ-C30 summary score was found between the experimental and control groups over time (Additional file 1: Table S1).”
Quoted verbatim from Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study.. - Study
- RCT
- Dose
- sodium selenite pentahydrate 2000 ug/40 mL intravenously over two hours before each chemotherapy cycle, six cycles every 3 weeks
- Population
- patients with platinum-sensitive recurrent ovarian cancer receiving paclitaxel, carboplatin and bevacizumab in both arms; selenium arm against intravenous normal saline placebo, group-by-time repeated-measures ANOVA
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study.2026PMID:4163001710.1186/s12916-026-04637-xIndustry fundedPermalink
To cite this finding: https://catalystproject.ai/e/01M5MWTFP2XR1FFRYSM6S42XH6